Aura Biosciences, Inc. AURA Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s operating cash flow?
- Aura Biosciences, Inc. (AURA) reported operating cash flow of -$29.89M in Q1 2026.
- How has Aura Biosciences, Inc.'s operating cash flow changed year-over-year?
- Aura Biosciences, Inc.'s operating cash flow decreased by 28.0% year-over-year, from -$23.36M to -$29.89M.
- What is the long-term trend for Aura Biosciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s operating cash flow has grown at a 27.2% compound annual growth rate (CAGR), from -$32.41M to -$84.74M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.